CoSyne is a visionary drug discovery company applying polymathic AI to transform the way medicines are discovered
Focusing on moonshot projects, our compound discovery engine is combined with our target discovery engine to create a step change in the way drugs are developed: hypothesis-free drug discovery that can address devastating diseases from the ground up.
We have built a proprietary pipeline targeting rare, fatal orphan diseases.
Our team is passionate, visionary and pragmatic. We bring together interdisciplinary skills from across the drug development process, spanning target discovery, AI, chemistry, clinical trials and treating patients in hospital.